807315-42-0

Basic information

• Product Name: 1-phenethyl-piperidine-4-carboxylic acid
• Synonyms: 1-phenethyl-piperidine-4-carboxylic acid
• CAS NO: 807315-42-0
• Molecular Weight: 233.31
• Mol File: 807315-42-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-phenethyl-piperidine-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-phenethyl-piperidine-4-carboxylic acid(807315-42-0)
• EPA Substance Registry System: 1-phenethyl-piperidine-4-carboxylic acid(807315-42-0)

Safety Data

• Hazardous Substances Data: 807315-42-0(Hazardous Substances Data)

Upstream product

• 100-42-5 styrene 
• 498-94-2 isonipecotic acid 
• 103-63-9 1-phenyl-2-bromoethane 
• 24228-41-9 1-(phenylethyl)-4-(ethoxycarbonyl)piperidine 

Downstream Products

• 1463609-42-8 1H-1-oxa-2-aza-6-chloro-3-(1-phenethylpiperidin-4-yl)-1,4dihydroindeno[2,1-d]isoxazole 
• 1463609-43-9 2H-1-aza-2-oxa-6-chloro-3-(1-phenethylpiperidin-4-yl)-1,4dihydroindeno[1,2-c]isoxazole 
• 1463609-41-7 phenyl 1-phenethylpiperidine-4-carboxylate 
• 383362-71-8 4-[(Bis(4-fluorophenyl)methylamino)methyl]-1-[2-(phenyl)ethyl]piperidine 

Relevant articles and documents

Synthetic method of anesthetic analgesic drug

The invention discloses a synthetic method of an anesthetic analgesic drug. According to the synthetic method, 4-piperidinecarboxylic acid is used as a raw material and subjected to alkylation, bromination, methylation, acylation and the like to prepare the anesthetic analgesic drug. The method avoids the usage of highly toxic cyanide, so the safety and controllability of operation are improved; the method avoids an elimination reaction in reaction process, thereby accelerating reaction speed and shortening reaction time; and the method reduces reaction temperature, shortens the reaction time,and is more suitable for industrial production.

Structure - Activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: Evaluation of behavioral activity of O- and N-analogues and their binding to monoamine transporters

In our effort to develop a pharmacotherapy for the treatment of cocaine addiction, we embarked on synthesizing novel molecules targeting the dopamine transporter (DAT) molecule in the brain as DAT has been implicated strongly in the reinforcing effect of